MiniMed invests in implantable glucose sensors
This article was originally published in Clinica
Executive Summary
Insulin pump company MiniMed has exercised its option to acquire worldwide marketing rights to Medical Research Group (MRG)'s long-term implantable glucose sensor, paying $30 million. It will also make an equity investment of up to $30 million in the company, representing 8% of MRG.